Biotech Company Picks City: Glenveigh Breaks Out of the Research Triangle in North Carolina (RedNova)
By Emily Bregel, Chattanooga Times/Free Press, Tenn. Mar. 31--A Chattanooga physician believes the Scenic City has what it takes to become a medical research hub -- and he wants his biotech company to be a part of it.

KV Pharmaceutical Company Acquires U.S. Rights to EvaMist(TM) - A Novel New Product for the Treatment of the Symptoms ... (PR Newswire via Yahoo! Finance)
KV Pharmaceutical Company announced today that it has entered into an agreement with California-based VIVUS, Inc. for the purchase of U.S. marketing rights to EvaMist, a novel new estrogen transdermal spray that has been developed to deliver estradiol in a convenient easy-to-use dosage form for the treatment of vasomotor symptoms associated with menopause.